Global Standard of Care

trophon®2 is fast becoming the global standard of care for ultrasound probe reprocessing.

As a market leader in automated ultrasound reprocessing systems, Nanosonics’ trophon technology helps protect patients by delivering consistent high level disinfection (HLD) of ultrasound probes with every automated cycle.

trophon2 devices are manufactured in Australia and with an expanding global network of offices in major markets including USA, Canada, UK, France, Germany, Ireland, Japan and Australia along with an expanding distributor base across the world, Nanosonics has an established global supply chain to continue to provide unparalleled service and supply.

The global trophon device installed base has now increased to over 25,000 units worldwide as more facilities continue to trust trophon technology to deliver reliable, automated HLD. 

The fully enclosed trophon technology generates a 'sonically activated' hydrogen peroxide (H2O2) mist which accesses all surfaces of the suspended probe, ensuring all crevices and imperfections of the probe surface are high level disinfected. The only by-products of the HLD cycle are oxygen and water. trophon devices therefore effectively delivers HLD without damaging the sensitive probe surface, nor exposing patients, staff or the environment to harmful chemicals.

As a fully automated reprocessing system designed with the user in mind, trophon2 technology offers advanced workflow efficiencies. With traceability across the operator, probe and cycle parameters, trophon devices help demonstrate user compliance for survey and audit reporting.

With over 25,000 trophon devices now installed in major markets across the world, more than 80,000 patients every day are protected from the risk of ultrasound probe cross contamination.

The trophon family includes trophonEPR and trophon2 which share the same core technology of 'sonically activated' hydrogen peroxide.